Beta Bionics Chief Commercial Officer Hopman Mark sold 5,327 shares at $19.11 each on September 2, 2026. The transaction left Hopman Mark holding 124,027 Beta Bionics shares, giving investors the stated post-transaction ownership figure for the executive in the company.

Key Highlights

  • The transaction took place on September 2, 2026.
  • Hopman Mark serves as Beta Bionics' Chief Commercial Officer.
  • Hopman Mark owned 124,027 shares after the transaction.

Beta Bionics, Inc. (NASDAQ: BBNX) Chief Commercial Officer Hopman Mark sold 5,327 shares at $19.11 per share. The transaction occurred on September 2, 2026, and the reported post-transaction ownership was 124,027 shares.

Beta Bionics Officer Sale Details

Hopman Mark’s role at Beta Bionics is Chief Commercial Officer. The reported date was September 2, 2026. Beta Bionics, Inc. is the company named in connection with the transaction, and BBNX is its listed symbol. The sale price was stated on a per-share basis. The reported quantity refers to shares sold by Hopman Mark.

124,027 Shares Owned After Transaction

Following the transaction, Hopman Mark owned 124,027 Beta Bionics shares. That figure is the stated ownership position after the sale. The reported post-transaction holding identifies the number of Beta Bionics shares owned by Hopman Mark after the September 2 transaction. The transaction information connects the 124,027 shares with the company’s Chief Commercial Officer.